author-photo

Murali Sundaram

Saint Louis University
Cleveland Clinic
Mayo Clinic

397

Papers

7197

Citations

Citation Trend

Filter By

Papers (397) Sort By

JournalConferenceOthers

PCN164 Impact of Treatment and Patient Attributes on Oncologists Decision-Making in First-line Chronic Lymphocytic Leukemia (CLL) in the United States (US)

2021 Value in Health
Show All
- Source
- Cite
- Save
Citations (0)
Healthcare resource utilization and costs associated with first-line ibrutinib compared to chemoimmunotherapy treatment among Medicare beneficiaries with chronic lymphocytic leukemia.

2020 Current Medical Research and Opinion
Show All
- Source
- Cite
- Save
Citations (0)
Primary bone tumours

2020
Show All
- Source
- Cite
- Save
Citations (0)
Time to Next Treatment, Health Care Resource Utilization, and Costs Associated with Ibrutinib Use Among U.S. Veterans with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Real-World Retrospective Analysis.

2020 Journal of Managed Care Pharmacy
Show All
- Source
- Cite
- Save
Citations (1)
HSR20-107: Health-Related Quality of Life and Treatment Satisfaction in Chronic Lymphocytic Leukemia (CLL) Patients on Ibrutinib Compared to a Reference Group on Other CLL Treatments in a Real-World US Cross-Sectional Study

2020 Journal of The National Comprehensive Cancer Network
Show All
- Source
- Cite
- Save
Citations (0)
PCN366 TREATMENT AND PROGNOSTIC TESTING PATTERNS IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA: THE INFORMCLL™ REAL-WORLD REGISTRY INTERIM ANALYSIS

2020 Value in Health
Show All
- Source
- Cite
- Save
Citations (0)
PCN124 REAL-WORLD HEALTHCARE RESOURCE UTILIZATION AND TOTAL COST OF CARE AMONG US MEDICARE PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA RECEIVING FIRST-LINE IBRUTINIB VS CHEMOIMMUNOTHERAPY

2020 Value in Health
Show All
- Source
- Cite
- Save
Citations (1)
Bony changes of the tibia secondary to pes anserine bursitis mimicking neoplasm

2019 Skeletal Radiology
Show All
- Source
- Cite
- Save
Citations (2)
First-line Ibrutinib Treatment is Associated with Longer Time to Next Treatment in a Real-World US Veterans Population

2019 Clinical Lymphoma, Myeloma & Leukemia
Show All
- Source
- Cite
- Save
Citations (0)
Comparison of Time to Next Treatment, Healthcare Resource Utilization, and Costs in Patients with Chronic Lymphocytic Leukemia Initiated on Front-Line Ibrutinib or Chemoimmunotherapy

2019 Clinical Lymphoma, Myeloma & Leukemia
Show All
- Source
- Cite
- Save
Citations (6)

© Copyright 2015-2020 Acemap, Inc. Shanghai Jiao Tong University.

沪ICP备18028330号